Soleno Therapeutics (SLNO) EBT Growth (5y) (2018 - 2026)
Soleno Therapeutics (SLNO) EBT Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.19% |
| Dec 31, 2025 | 49.49% |
| Sep 30, 2025 | -57.62% |
| Jun 30, 2025 | -71.01% |
| Mar 31, 2025 | -33.91% |
| Dec 31, 2024 | -52.48% |
| Sep 30, 2024 | -94.29% |
| Jun 30, 2024 | -67.28% |
| Mar 31, 2024 | -78.94% |
| Dec 31, 2023 | 18.10% |
| Sep 30, 2023 | -68.53% |
| Jun 30, 2023 | -16.72% |
| Mar 31, 2023 | -18.64% |
| Dec 31, 2022 | -16.86% |
| Sep 30, 2022 | -19.81% |
| Jun 30, 2022 | -19.19% |
| Mar 31, 2022 | -35.31% |
| Dec 31, 2021 | -9.92% |
| Sep 30, 2021 | -33.47% |
| Jun 30, 2021 | -38.51% |